Terns Pharmaceuticals
TERN • NASDAQ
Terns Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Amy L. Burroughs, with a market cap of $4.9B.
CEOAmy L. Burroughs
Next Earnings
Upcoming earnings announcement for Terns Pharmaceuticals
Date
Thursday, May 7, 2026 (in 2 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.29
Earnings History
Past 11 earnings reports for Terns Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | Q3 2025 | -$0.27Est: -$0.30 | +10.0% | - | — |  10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.26Est: -$0.28 | +7.1% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.26Est: -$0.27 | +3.7% | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.24Est: -$0.30 | +20.0% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.28Est: -$0.34 | +17.6% | - | — | 10-Q |
| Aug 5, 2024 | Q2 2024 | -$0.31Est: -$0.34 | +8.8% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.30Est: -$0.34 | +11.8% | - | — | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$0.29Est: -$0.29 | 0.0% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.42Est: -$0.30 | -40.0% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.25Est: -$0.34 | +26.5% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.31Est: -$0.27 | -14.8% | - | — | 10-Q |